IFNA2 and neoplasm: To understand the autocrine regulation of type I IFN release by either tumor or host cells, we subjected tumor cell lines and bone marrow-derived myeloid cells (BMMCs) or bone-marrow derived dendritic cells (BMDCs) to a 24-h stimulation with recombinant IFNα.